Business Development and Corporate Strategy - Ms. Malseed is a seasoned legal executive leveraging business development practice with two decades of R&D guidance, intellectual property management and commercial law. Ms. Malseed has served as senior management for several technology start-ups such as OncoRX, LIMR Development Inc, Wild-Type Enterprises, Phoenix LLC and Cytel Corp

Research and Development - Dr. Schmidt has more than 20 years preclinical development experience at Merck and Co. Dr. Schmidt has a proven track record of successfully managing lead optimization and IND-enabling programs in multiple therapeutic area, including oncology.

Executive Chairman and co-Founder, Dr. Ben-Maimon was most recently President of Global Pharmaceuticals, IMPAX Laboratories, Inc. Prior to that she held roles as Senior Vice President Corporate Strategy at Qualitest Pharmaceuticals, founder and CEO of Alita Pharmaceuticals, President and COO at Duramed Research Inc. and Senior Vice President at Teva Pharmaceuticals.

President, CSO, and co-Founder, Dr. Bettoun has over 15 years of preclinical pharmaceutical experience. He is a small molecules expert who has successfully managed all stages of preclinical discovery programs at Eli Lilly, Merck, and GlaxoSmithKline.